
Cefdoray 100mg Tablet DT
Marketer
Rayh Health Care
Salt Composition
Cefpodoxime Proxetil (100mg)
Overview Cefdoray 100mg Tablet DT
Dorcef 100mg Delayed-Release Tablets are an antibacterial medication combating bacterial infections. Effective against infections affecting the lungs (pneumonia, for example), urinary tract, ears, sinuses, throat, and skin, it eradicates bacteria, alleviating symptoms and resolving the infection. Dorcef 100mg tablets should be ingested with food, consistently at evenly spaced intervals as directed by your physician. Maintaining a regular schedule aids adherence. Dosage varies depending on the treated infection; however, always complete the prescribed course. Premature cessation may allow bacterial resurgence. Ineffective against viral infections like influenza or colds, unnecessary antibiotic use diminishes future efficacy. Common side effects include skin rash, nausea, and loose stools. Consuming this medication with food can mitigate digestive upset. Report bothersome side effects to your doctor. Inform your doctor of antibiotic allergies, kidney, or liver issues prior to use. Generally safe during pregnancy and breastfeeding under medical supervision, it may cause blurred vision, drowsiness, or dizziness. Refrain from driving if experiencing these symptoms.
Uses of Cefdoray 100mg Tablet DT
Combating Bacterial Infections
Major Benefits of Cefdoray 100mg Tablet DT:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Cefdoray 100mg Tablet DT in water before consumption. Administer with a meal.
Common Side effects of Cefdoray 100mg Tablet DT:
- Rash
- Nausea
- Diarrhea
How to use Cefdoray 100mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Cefdoray 100mg Tablet DT in water before consumption. Administer this medication with food.
How Cefdoray 100mg Tablet DT works:
Cefdoray 100mg Delayed-Release tablets are a bacterial-killing antibiotic. Its mechanism of action disrupts bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol ingestion and Cefdoray 100mg Tablet DT.
PregnancySAFE IF PRESCRIBED
The use of Cefdoray 100mg Delayed-Release Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Cefdoray 100mg Delayed-Release Tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing negligible risk to the infant. However, extended use of Cefdoray 100mg Delayed-Release Tablets should be avoided due to potential side effects including skin rashes and diarrhea.
DrivingUNSAFE
Driving may be impaired by Cefdoray 100mg Delayed-Release Tablets, which can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use Cefdoray 100mg Delayed-Release Tablets cautiously. Dosage modification for Cefdoray 100mg Delayed-Release Tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Cefdoray 100mg sustained-release tablets are considered safe for use by individuals with hepatic impairment. No alteration of the Cefdoray 100mg sustained-release tablet dosage is necessary.
What if you forget to take Cefdoray 100mg Tablet DT :
Should you forget a Cefdoray 100mg Tablet DT dose, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cefdoray 100mg Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
| Actions | Third-generation Cephalosporins |
